Cue Biopharma (CUE) Institutional Ownership $1.01 -0.03 (-2.88%) (As of 01:48 PM ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Institutional Ownership Changes (13F Filings) for Cue Biopharma (NASDAQ:CUE)CurrentInstitutional OwnershipPercentage35.04%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$728.38KNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$1.01M Get CUE Insider Trade Alerts Want to know when executives and insiders are buying or selling Cue Biopharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CUE Institutional Buying and Selling by Quarter Ad Brownstone ResearchCould This Tiny Device Help You Make an Extra $30k a Year?I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich. Cue Biopharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/16/2024 Geode Capital Management LLC508,827$385K0.0%+3.3%1.046% 11/5/2024 GSA Capital Partners LLP291,663$221K0.0%+5.1%0.600% 11/4/2024 Sigma Planning Corp401,325$304K0.0%+50.9%0.825% 10/16/2024 Good Life Advisors LLC400,000$303K0.0%+23.1%0.822% 9/16/2024 Point72 Asia Singapore Pte. Ltd.53,027$66K0.0%N/A0.109% 8/15/2024 Point72 Asia Singapore Pte. Ltd.53,027$66K0.0%N/A0.109% Get the Latest News and Ratings for CUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cue Biopharma and its competitors with MarketBeat's FREE daily newsletter. 8/9/2024 Dimensional Fund Advisors LP214,089$266K0.0%-50.4%0.440% 8/7/2024 Monaco Asset Management SAM253,185$314K0.1%-24.4%0.521% 5/14/2024 Carlson Capital L P20,000$38K0.0%-83.3%0.041% 5/10/2024 Vanguard Group Inc.2,283,362$4.32M0.0%+7.1%4.694% 5/9/2024 Monaco Asset Management SAM334,742$633K0.2%-2.2%0.688% 4/10/2024 Wedmont Private Capital40,000$76K0.0%+100.0%0.082% 2/8/2024 Legacy Capital Group California Inc.10,000$26K0.0%N/A0.022% 2/7/2024 Monaco Asset Management SAM342,242$904K0.3%-4.9%0.759% 2/1/2024 Sigma Planning Corp108,875$287K0.0%-55.5%0.241% 1/18/2024 Navalign LLC25,000$66K0.0%N/A0.055% 1/18/2024 Good Life Advisors LLC100,000$264K0.0%-10.7%0.222% 11/7/2023 Monaco Asset Management SAM359,739$827K0.2%-2.9%0.800% 11/7/2023 New York State Common Retirement Fund11,984$28K0.0%-53.4%0.027% 11/6/2023 Sigma Planning Corp244,705$563K0.0%+8.6%0.544% 10/24/2023 Channel Wealth LLC15,300$35K0.0%-77.7%0.034% 10/13/2023 Sanders Morris Harris LLC346,212$796K0.2%+513.6%0.770% 9/21/2023 Barclays PLC12,946$48K0.0%+114.7%0.029% 8/15/2023 Silverarc Capital Management LLC403,402$1.47M0.5%+31.7%0.897% 8/10/2023 Carlson Capital L P134,036$489K0.0%-47.2%0.310% 8/8/2023 Monaco Asset Management SAM370,407$1.35M0.4%-20.6%0.858% 8/4/2023 American International Group Inc.16,635$61K0.0%N/A0.039% 8/2/2023 Sigma Planning Corp225,300$822K0.0%+2.0%0.522% 7/27/2023 Virtu Financial LLC17,594$64K0.0%N/A0.041% 7/26/2023 Channel Wealth LLC68,700$251K0.1%+14.4%0.159% 7/13/2023 Cambridge Investment Research Advisors Inc.20,000$73K0.0%N/A0.046% 7/11/2023 Sanders Morris Harris LLC56,420$199K0.0%N/A0.131% 5/12/2023 Prosight Management LP1,151,855$4.11M1.9%-37.4%2.668% 5/8/2023 Sigma Planning Corp220,889$789K0.0%+14.6%0.512% 5/1/2023 P.A.W. Capital Corp150,000$536K1.2%-16.7%0.347% 4/27/2023 Channel Wealth LLC60,050$214K0.1%N/A0.139% 4/18/2023ETF Managers Group LLC13,528$48K0.0%N/A0.031% 2/13/2023 Voss Capital LLC125,000$356K0.1%-37.5%0.290% 2/13/2023 GSA Capital Partners LLP188,308$537K0.1%-12.9%0.438% 2/10/2023 Good Life Advisors LLC75,000$214K0.0%+31.6%0.174% Wall St. Icon: “If you wait on this, it will already be too late” (Ad)If you have a significant amount of money in the stock market right now — or if you're sitting on the sidelines waiting to make a move — you DO NOT want to miss my latest research.Go here now to see my urgent warning2/10/2023 Connor Clark & Lunn Investment Management Ltd.22,970$65K0.0%-29.7%0.053% 2/3/2023 Monaco Asset Management SAM497,177$1.42M0.4%+8.4%1.155% 2/1/2023 Bank of Montreal Can33,900$98K0.0%N/A0.079% 1/31/2023 Monaco Asset Management SAM497,177$1.42M0.4%+8.4%1.155% 1/24/2023 Sigma Planning Corp192,734$549K0.0%+2.3%0.448% 1/13/2023 Sanders Morris Harris LLC56,420$161K0.1%-93.3%0.131% 11/15/2022 Prosight Management LP1,545,573$3.45M1.8%-6.6%4.368% 11/15/2022 Carlson Capital L P535,000$1.19M0.1%-7.8%1.512% 11/14/2022 Annandale Capital LLC65,000$145K0.1%N/A0.184% 11/14/2022Ergoteles LLC117,074$261K0.0%-14.2%0.331% 11/10/2022 Sigma Planning Corp188,424$420K0.0%+12.8%0.533% 11/10/2022 Nantahala Capital Management LLC93,297$208K0.0%-7.1%0.264% 11/10/2022 Connor Clark & Lunn Investment Management Ltd.32,677$73K0.0%N/A0.092% 11/2/2022 Voss Capital LLC200,000$446K0.1%+100.0%0.565% 11/1/2022 P.A.W. Capital Corp200,000$446K0.7%+14.3%0.565% 10/31/2022 Monaco Asset Management SAM458,851$1.02M0.4%+3.4%1.297% 10/13/2022 Newbridge Financial Services Group Inc.17,000$38K0.0%+41.7%0.048% 10/7/2022 Sanders Morris Harris LLC848,048$2.02M0.5%+15.2%2.397% 8/16/2022 Delphia USA Inc.10,126$25K0.0%N/A0.029% 8/15/2022 Nantahala Capital Management LLC100,464$250K0.0%-95.5%0.284% 8/13/2022 Voss Capital LLC100,000$249K0.1%N/A0.283% 8/13/2022 Prosight Management LP1,655,477$4.12M3.2%+9.6%4.679% 8/12/2022 Ensign Peak Advisors Inc17,960$45K0.0%+72.7%0.051% 8/11/2022 Sigma Planning Corp167,106$416K0.0%+28.8%0.472% 8/1/2022 Monaco Asset Management SAM443,851$1.11M0.5%+886.3%1.255% 7/19/2022 Good Life Advisors LLC57,000$142K0.0%N/A0.161% 7/15/2022 Newbridge Financial Services Group Inc.12,000$30K0.0%+200.0%0.034% 7/13/2022 P.A.W. Capital Corp175,000$436K0.6%+16.7%0.495% 7/11/2022 Sanders Morris Harris LLC736,212$1.80M0.4%-15.7%2.081% 6/30/2022 Amalgamated Bank5,025$25K0.0%N/A0.014% 5/17/2022 Prosight Management LP1,510,282$7.37M4.8%+82.2%4.270% 5/11/2022 Bleichroeder LP552,000$2.69M0.5%+176.0%1.672% 5/11/2022 GSA Capital Partners LLP96,563$471K0.1%-3.3%0.293% 5/9/2022 WealthShield Partners LLC29,951$146K0.0%+161.7%0.091% 5/9/2022 Monaco Asset Management SAM45,000$220K0.1%N/A0.136% 5/4/2022 Advisor Group Holdings Inc.38,182$2.41M0.0%+43.4%0.116% 4/21/2022Virginia Retirement Systems ET AL11,000$54K0.0%-31.3%0.033% 4/21/2022 P.A.W. Capital Corp150,000$732K0.8%+25.0%0.454% 4/20/2022 Sigma Planning Corp129,728$633K0.0%+51.0%0.393% 4/11/2022 Sanders Morris Harris LLC873,021$4.26M0.8%+143.1%2.645% 2/14/2022 GSA Capital Partners LLP99,816$1.13M0.1%-18.0%0.314% 2/11/2022Granite Point Capital Management L.P.110,000$1.24M0.2%N/A0.346% 2/11/2022 Ensign Peak Advisors Inc10,400$118K0.0%N/A0.033% 2/10/2022 Bleichroeder LP200,000$2.26M0.4%+14.3%0.630% 2/10/2022 Rafferty Asset Management LLC97,062$1.10M0.0%+148.8%0.306% 2/10/2022 WealthShield Partners LLC11,444$129K0.0%-38.5%0.036% 2/10/2022 Citigroup Inc.80,185$907K0.0%+184.3%0.252% 2/10/2022 P.A.W. Capital Corp120,000$1.36M1.2%-4.0%0.378% 2/9/2022 BNP Paribas Arbitrage SA21,294$241K0.0%+277.9%0.067% 2/9/2022 Dimensional Fund Advisors LP849,343$9.61M0.0%+360.1%2.674% Could This Tiny Device Help You Make an Extra $30k a Year? (Ad)I believe it’s going to power Elon Musk’s next AI revolution… A revolution he believes will be worth more than $9 trillion. That’s nearly 10 times more money than the market caps of Tesla… SpaceX… PayPal… Neuralink… and X… COMBINED.Click here to see the details because I believe a lot of people will get rich.2/8/2022 Northern Trust Corp316,467$3.58M0.0%+2.2%0.996% 2/3/2022 Advisor Group Holdings Inc.26,620$301K0.0%-14.7%0.084% 2/3/2022Virginia Retirement Systems ET AL16,000$181K0.0%+29.0%0.050% 2/2/2022 Sanders Morris Harris LLC359,113$4.42M0.8%+17.5%1.131% 2/2/2022 Sigma Planning Corp85,893$971K0.0%+2.0%0.270% 1/25/2022 Belvedere Trading LLC19,819$178K0.0%N/A0.062% 11/16/2021 Two Sigma Advisers LP202,000$2.94M0.0%-32.2%0.636% 11/16/2021 Two Sigma Investments LP103,430$1.51M0.0%-48.5%0.326% 11/15/2021 California State Teachers Retirement System39,229$572K0.0%-4.5%0.124% 11/15/2021 Marshall Wace LLP26,340$384K0.0%-16.8%0.083% (Data available from 1/1/2016 forward) CUE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CUE shares? During the previous two years, 26 institutional investors and hedge funds held shares of Cue Biopharma. The most heavily invested institutionals were Vanguard Group Inc. ($4.32M), Prosight Management LP ($4.11M), Silverarc Capital Management LLC ($1.47M), Sanders Morris Harris LLC ($796K), P.A.W. Capital Corp ($536K), Geode Capital Management LLC ($385K), and Voss Capital LLC ($356K).Learn more on CUE's institutional investors. What percentage of Cue Biopharma stock is owned by institutional investors? 35.04% of Cue Biopharma stock is owned by institutional investors. Learn more on CUE's institutional investor holdings. Which institutional investors have been buying Cue Biopharma stock? Of the 19 institutional investors that purchased Cue Biopharma stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Sanders Morris Harris LLC ($346.21K), Sigma Planning Corp ($191.58K), Vanguard Group Inc. ($150.46K), Point72 Asia Singapore Pte. Ltd. ($106.05K), Silverarc Capital Management LLC ($97.12K), Good Life Advisors LLC ($93K), and Monaco Asset Management SAM ($76.65K). How much institutional buying is happening at Cue Biopharma? Institutional investors have bought a total of 1,323,824 shares in the last 24 months. This purchase volume represents approximately $3.01M in transactions. Which Cue Biopharma major shareholders have been selling company stock? Of the 13 institutional investors that sold Cue Biopharma stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Sanders Morris Harris LLC ($791.63K), Prosight Management LP ($688.66K), Carlson Capital L P ($220K), Dimensional Fund Advisors LP ($217.22K), Monaco Asset Management SAM ($213.16K), Sigma Planning Corp ($135.83K), and Voss Capital LLC ($75K). How much institutional selling is happening at Cue Biopharma? Institutional investors have sold a total of 2,488,257 shares in the last 24 months. This volume of shares sold represents approximately $7.12M in transactions. Related Companies Rezolute Major Shareholders Fulcrum Therapeutics Major Shareholders UroGen Pharma Major Shareholders Eledon Pharmaceuticals Major Shareholders Heron Therapeutics Major Shareholders Aurora Cannabis Major Shareholders Zentalis Pharmaceuticals Major Shareholders DiaMedica Therapeutics Major Shareholders ProQR Therapeutics Major Shareholders SOPHiA GENETICS Major Shareholders This page (NASDAQ:CUE) was last updated on 12/24/2024 by MarketBeat.com Staff From Our PartnersURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredSix Stocks That Could Soar on Trump’s First Day BackThe recent election results have clarified a path forward, creating opportunities that weren't as clear just m...InvestorPlace | SponsoredTSLA *BANG* incoming (bullet in the chamber rn)I just pinpointed 5 dirt-cheap stocks that could soar the second the shot goes off. Thanks to Donald Trump’...StocksToTrade | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored"This looks and feels like 2000," says investing legendOur senior analyst Dan Ferris says a new surprise crisis could begin at any moment... and this time, he says i...Stansberry Research | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cue Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cue Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CUE Stock Alerts